<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>11(1)</volume><submitter>Pang SY</submitter><funding>The Henry G. Leong Endowed Professorship in Neurology</funding><funding>Tai Hung Fai Charitable Foundation - Edwin S H Leong Research Programme for Parkinson’s Disease</funding><funding>The Donation Fund for Neurology Research</funding><pubmed_abstract>Mutations in leucine-rich repeat kinase 2 (LRRK2) and glucocerebrosidase (GBA) represent two most common genetic causes of Parkinson's disease (PD). Both genes are important in the autophagic-lysosomal pathway (ALP), defects of which are associated with α-synuclein (α-syn) accumulation. LRRK2 regulates macroautophagy via activation of the mitogen activated protein kinase/extracellular signal regulated protein kinase (MAPK/ERK) kinase (MEK) and the calcium-dependent adenosine monophosphate (AMP)-activated protein kinase (AMPK) pathways. Phosphorylation of Rab GTPases by LRRK2 regulates lysosomal homeostasis and endosomal trafficking. Mutant LRRK2 impairs chaperone-mediated autophagy, resulting in α-syn binding and oligomerization on lysosomal membranes. Mutations in GBA reduce glucocerebros</pubmed_abstract><journal>Translational neurodegeneration</journal><pagination>5</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC8805403</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>LRRK2, GBA and their interaction in the regulation of autophagy: implications on therapeutics in Parkinson's disease.</pubmed_title><pmcid>PMC8805403</pmcid><pubmed_authors>Ramsden DB</pubmed_authors><pubmed_authors>Wong WY</pubmed_authors><pubmed_authors>Malki Y</pubmed_authors><pubmed_authors>Choi ZY</pubmed_authors><pubmed_authors>Chang EES</pubmed_authors><pubmed_authors>Ho PW</pubmed_authors><pubmed_authors>Pang SY</pubmed_authors><pubmed_authors>Liu HF</pubmed_authors><pubmed_authors>Ho SL</pubmed_authors><pubmed_authors>Lo RCN</pubmed_authors><pubmed_authors>Leung CT</pubmed_authors><pubmed_authors>Kung MH</pubmed_authors></additional><is_claimable>false</is_claimable><name>LRRK2, GBA and their interaction in the regulation of autophagy: implications on therapeutics in Parkinson's disease.</name><description>Mutations in leucine-rich repeat kinase 2 (LRRK2) and glucocerebrosidase (GBA) represent two most common genetic causes of Parkinson's disease (PD). Both genes are important in the autophagic-lysosomal pathway (ALP), defects of which are associated with α-synuclein (α-syn) accumulation. LRRK2 regulates macroautophagy via activation of the mitogen activated protein kinase/extracellular signal regulated protein kinase (MAPK/ERK) kinase (MEK) and the calcium-dependent adenosine monophosphate (AMP)-activated protein kinase (AMPK) pathways. Phosphorylation of Rab GTPases by LRRK2 regulates lysosomal homeostasis and endosomal trafficking. Mutant LRRK2 impairs chaperone-mediated autophagy, resulting in α-syn binding and oligomerization on lysosomal membranes. Mutations in GBA reduce glucocerebros</description><dates><release>2022-01-01T00:00:00Z</release><publication>2022 Jan</publication><modification>2025-04-19T10:50:05.266Z</modification><creation>2025-04-19T10:50:05.266Z</creation></dates><accession>S-EPMC8805403</accession><cross_references><pubmed>35101134</pubmed><doi>10.1186/s40035-022-00281-6</doi></cross_references></HashMap>